Nasus Pharma Ltd Cash and Restricted Cash
Nasus Pharma Ltd (NSRX) had Cash and Restricted Cash of $1.29 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-25
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.29M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $232.00K.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $311.00K.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $916.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $1.29M 20-F · filed 2026-03-25 |
| 2025-06-30 | $232.00K 6-K · filed 2025-12-29 |
| 2024-12-31 | $311.00K 20-F · filed 2026-03-25 |
| 2024-06-30 | $916.00K 6-K · filed 2025-12-29 |
| 2023-12-31 | $210.00K 20-F · filed 2026-03-25 |